ReviewInternational journal of molecular medicine2025

The regulatory role of CDK4/6 inhibitors in tumor immunity and the potential value of tumor immunotherapy (Review).

Feifan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.